sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
ORIC
Updated 10/6/2026, 8:56 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| ORIC Oric Pharmaceuticals, Inc. | Sale | $86,524 | Heyman Richard A. Director | 6,700 sh | at $12.91 | Filed Oct 2, 5:50 PM ET | Filing | |
| ORIC Oric Pharmaceuticals, Inc. | Sale | $181,258 | Piscitelli Dominic Chief Financial Officer | 13,400 sh | at $13.53 | Filed Sep 29, 7:16 PM ET | Filing | |
| ORIC Oric Pharmaceuticals, Inc. | Sale | $8,103 | Piscitelli Dominic Chief Financial Officer | 600 sh | at $13.50 | Filed Sep 25, 7:59 PM ET | Filing | |
| ORIC Oric Pharmaceuticals, Inc. | Sale | $1,053,814 | Piscitelli Dominic Chief Financial Officer | 77,000 sh | at $13.69 | Filed Aug 28, 4:11 PM ET | Filing | |
| ORIC Oric Pharmaceuticals, Inc. | Sale | $157,462 | Heyman Richard A. Director | 13,100 sh | at $12.02 | Filed Jul 28, 4:15 PM ET | Filing | |
| ORIC Oric Pharmaceuticals, Inc. | Sale | $3,600 | Heyman Richard A. Director | 300 sh | at $12.00 | Filed Jul 8, 4:35 PM ET | Filing |